TrialJournal for immunotherapy of cancer2026

Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.

Maria Gonzalez-Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.